Our Journal

Clinical and Experimental Rheumatology

Home Journal of the Society: iMyoS has partnered with the excellent Journal Clinical Experimental Rheumatology (CER, current impact factor: 4.47) as home Journal of the Society. As part of this collaboration, future proceedings of the international myositis conference (GCOM) and global guidelines and standards of care will be expected to be published in this Journal. As part of the Journal’s commitment, one thematic issue on myositis will be published each year and members of iMyoS will serve as guest editors and editorial board members. Articles on Myositis currently in press in CER will be announced regularly in our newsletter.